Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer

Fig. 1

RUNX1 expression in colorectal cancer tissues. a RUNX1 is highly expressed in the majority of gastrointestinal tumors (TCGA database online website GEPIA: http://gepia.cancer-pku.cn/). b The expression level of RUNX1 mRNA in colorectal cancer is higher than that in normal tissues. (Database source: TCGA (n = 465) and GSE106582 (n = 117)). c The expression level of RUNX1 mRNA in colorectal cancer is higher than that in the paired normal tissues. (Database source: TCGA (n = 41) and GSE106582 (n = 68)). d Positive correlation between colorectal cancer and RUNX1 expression was shown using TCGA (n = 465). e Percent of disease free survival and overall survival with low RUNX1 expression was higher than that with high RUNX1 expression, given by GEPIA. f mRNA expression of RUNX1 detected by qRT-PCR in colorectal cancer is higher than that in the paired non-cancerous tissues (n = 61). g RUNX1 protein expression in 12 pairs of colorectal cancer tissues is higher that than in adjacent non-tumor tissues

Back to article page